Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Cappella Medical Devices

Request full access

Cappella Medical Devices develops novel solutions for the treatment of complex coronary artery disease and bifurcation vascular disease.

Galway, IrelandFounded 2005Health Tech & Medtech

About Cappella Medical Devices

Founded in 2004 by Dr. Antonio Colombo and Dr. Ascher Shmulewitz, Cappella Medical Devices carved a niche in the complex field of coronary artery disease, specifically focusing on bifurcation lesions where a main coronary artery and a side branch artery are both affected. The company's operations are headquartered in Galway, Ireland, with a U.S. base in Westford, Massachusetts. The business was established to address the challenges interventional cardiologists face when treating these complex cases, which account for up to 30% of all percutaneous coronary intervention (PCI) procedures.

The core of Cappella's offering is the Sideguard® Coronary Sidebranch Stent and Delivery System. This product is a self-expanding nitinol stent designed to be placed in the side branch of a coronary artery first. Its unique trumpet-shaped flare at the proximal end is engineered to provide full coverage of the side branch opening (ostium), a critical area prone to complications. This 'side branch first' approach allows the cardiologist to then treat the main vessel with their preferred conventional stent, preserving access to the side branch and minimizing trauma to the vessel walls that can lead to restenosis. The delivery system features a proprietary split-sheath technology to ensure precise placement. The nitinol material provides a constant outward radial force, promoting continuous apposition to the vessel wall and positive remodeling over time.

Cappella Medical Devices operates in the interventional cardiology market, serving hospitals and cardiac catheterization labs. Its business model revolves around the development, manufacturing, and sale of its specialized stent systems. Revenue is generated through the distribution of the CE Mark-approved Sideguard system in Europe and South America. The company secured significant funding to support its growth, including a $17.3 million Series C round in 2009, which facilitated the European launch of the Sideguard stent and expanded R&D and manufacturing in Galway. In 2014, Cappella Medical Devices Ltd. was renamed ArraVasc Ltd., reflecting an expansion into the peripheral vascular market.

Source: Dealroom company data

Cappella Medical Devices in the Galway ecosystem

Live from Dealroom

The Cappella Medical Devices office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • PolyTechnos Venture Partners

Series B and later3 investors entered at this stage

  • Act Venture Capital
  • Fountain Healthcare Partners
  • Kreos Capital
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇮🇪 Ireland · Galway HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Cappella Medical Devices on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Cappella Medical Devices on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.